Literature DB >> 8095510

Inhibition of cell adhesion by microspheres coated with recombinant soluble intercellular adhesion molecule-1.

C A Welder1, D H Lee, F Takei.   

Abstract

Murine recombinant soluble intercellular adhesion molecule-1 (sICAM-1) was produced and characterized. When immobilized on plastic microtiter wells, sICAM-1 efficiently mediated LFA-1-dependent cell adhesion, indicating that the purified protein retained the ability to bind to LFA-1. However, sICAM-1 in solution, at concentrations up to 100 micrograms/ml, was incapable of inhibiting the phorbol ester-induced homotypic aggregation of lymphocytes, the adhesion of T cells to plastic immobilized sICAM-1, and CTL effector function, all of which are mediated by intercellular adhesion molecule-1:LFA-1 interaction. In contrast, uniform polystyrene microspheres coated with sICAM-1 bound specifically to LFA-1+ cells and efficiently inhibited the adhesion of T cells to immobilized sICAM-1. The sICAM-1-coated microspheres also inhibited CTL function, but the inhibition was only partial. These results suggest that although monomeric sICAM-1 cannot competitively inhibit cell adhesion mediated by intercellular adhesion molecule-1 and LFA-1, microspheres coated with sICAM-1 can inhibit such cell adhesion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095510

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Failure to block adhesion of Plasmodium falciparum-infected erythrocytes to ICAM-1 with soluble ICAM-1.

Authors:  A G Craig; R Pinches; S Khan; D J Roberts; G D Turner; C I Newbold; A R Berendt
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

2.  cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.

Authors:  Chuda Chittasupho; Prakash Manikwar; Jeffrey P Krise; Teruna J Siahaan; Cory Berkland
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

Review 3.  Intercellular adhesion molecules (ICAMs) and spermatogenesis.

Authors:  Xiang Xiao; Dolores D Mruk; C Yan Cheng
Journal:  Hum Reprod Update       Date:  2013-01-03       Impact factor: 15.610

4.  Antigen receptor engagement delivers a stop signal to migrating T lymphocytes.

Authors:  M L Dustin; S K Bromley; Z Kan; D A Peterson; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Nanoparticles targeting dendritic cell surface molecules effectively block T cell conjugation and shift response.

Authors:  Chuda Chittasupho; Laura Shannon; Teruna J Siahaan; Charlotte M Vines; Cory Berkland
Journal:  ACS Nano       Date:  2011-03-04       Impact factor: 15.881

Review 6.  Intercellular adhesion molecule-1.

Authors:  A van de Stolpe; P T van der Saag
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

7.  ICAM-1/LFA-1 interactions in T-lymphocyte activation and adhesion to cells of the blood-retina barrier in the rat.

Authors:  M Mesri; J Liversidge; J V Forrester
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

8.  Epidermal expression of intercellular adhesion molecule 1 is not a primary inducer of cutaneous inflammation in transgenic mice.

Authors:  I R Williams; T S Kupper
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

9.  T cell LFA-1 engagement induces HuR-dependent cytokine mRNA stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling cascade.

Authors:  Vinod S Ramgolam; Scott D DeGregorio; Gautham K Rao; Mark Collinge; Sharmila S Subaran; Silva Markovic-Plese; Ruggero Pardi; Jeffrey R Bender
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

10.  Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage.

Authors:  A Grothey; P Heistermann; S Philippou; R Voigtmann
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.